These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23340296)

  • 1. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
    Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
    Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer.
    Yu SJ; Yang L; Hong Q; Kuang XY; Di GH; Shao ZM
    BMC Cancer; 2018 Jan; 18(1):74. PubMed ID: 29329575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
    Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
    Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
    Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling.
    Du YE; Tu G; Yang G; Li G; Yang D; Lang L; Xi L; Sun K; Chen Y; Shu K; Liao H; Liu M; Hou Y
    Theranostics; 2017; 7(16):3972-3988. PubMed ID: 29109792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-6744-5p promotes anoikis in breast cancer and directly targets NAT1 enzyme.
    Malagobadan S; Ho CS; Nagoor NH
    Cancer Biol Med; 2020 Feb; 17(1):101-111. PubMed ID: 32296579
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma.
    Wang J; Song W; Shen W; Yang X; Sun W; Qu S; Shang R; Ma B; Pu M; Tao K; Dou K; Li H
    Oncol Res; 2017 Jan; 25(1):1-10. PubMed ID: 28081727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
    Zhang H; Liu H; Bi H
    Oncol Rep; 2017 Aug; 38(2):843-849. PubMed ID: 28677785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
    Xu R; Zeng G; Gao J; Ren Y; Zhang Z; Zhang Q; Zhao J; Tao H; Li D
    Oncol Rep; 2015 Oct; 34(4):2171-8. PubMed ID: 26239136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircATRNL1 promotes epithelial-mesenchymal transition in endometriosis by upregulating Yes-associated protein 1 in vitro.
    Wang D; Luo Y; Wang G; Yang Q
    Cell Death Dis; 2020 Jul; 11(7):594. PubMed ID: 32728069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma.
    Kang W; Tong JH; Lung RW; Dong Y; Zhao J; Liang Q; Zhang L; Pan Y; Yang W; Pang JC; Cheng AS; Yu J; To KF
    Mol Cancer; 2015 Feb; 14():52. PubMed ID: 25743273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
    Zhang MY; Lin J; Kui YC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.